Open AccessEvaluation of fractional erbium: YAG laser and glycolic acid 70% peeling in melasma improvement
Author(s) -
Hesham Aly Shokeir,
Wafaa Mohammad Ramadan,
Maha Rafie Abo Eittah,
Noura Abdel Moneim El Seessy
Publication year - 2022
Publication title -
international journal of health sciences (ijhs) (en línea)
Language(s) - English
Resource type - Journals
eISSN - 2550-6978
pISSN - 2550-696X
DOI - 10.53730/ijhs.v6ns3.5687
Subject(s) - melasma , medicine , glycolic acid , hyperpigmentation , dermatology , erbium , laser therapy , ablative case , laser , surgery , radiation therapy , lactic acid , bacteria , physics , biology , optics , genetics
Melasma is an acquired chronic hyperpigmentation which mainly affects women on sun-exposed areas of the body, especially on the face in Fitzpatrick skin types III-V. The study setting is at the Dermatology Clinic at NILES, Cairo University, Egypt. This study aims to evaluate the clinical efficacy and safety of fractional ablative erbium:YAG Laser therapy versus chemical peeling in treatment of melasma. This study included 30 patients with melasma on their face aged 20-50 years. The patients were divided into two groups. In group I, 15 patients were treated by four sessions of fractional erbium YAG laser at 4 weeks interval. In group II, 15 patients were treated by four sessions of chemical peeling with glycolic acid 70%.The percentage of improvement in patients treated by fractional erbium YAG laser was 20 – 80% with amean 54.33 ± 18.01 and the percentage of improvement in patients treated by chemical peeling was 30 – 85 % with a mean 53.33 ± 18.09. So, there was no significant difference in the percentage of improvement in both groups (P- value = 0.881). It was observed that fractional erbium YAG is as effective as 70% glycolic acid peel in patients with melasma.